Author

Scott Cooper

Observed name: S. Cooper

Institution: AbbVie (United Kingdom)

Observed institutions: Detroit Medical Center, Townsville Hospital, AbbVie (United Kingdom)

OpenAlex ID: A5047408387

A phase III, randomized, multicenter, open-label study of venetoclax or pomalidomide in combination with dexamethasone in patients with t(11;14)-positive relapsed/refractory multiple myeloma.

2020 · Maria-Victoria Mateos, Philippe Moreau, et al. · Journal of Clinical Oncology · 17

Obesity does not influence prostate intrafractional motion

2018 · Amy Brown, Alex Tan, et al. · Journal of Medical Radiation Sciences · 12

EPR19-066: Trends in Primary Squamous Cell Penile Cancer: A SEER Study

2019 · Scott Cooper, Mohammed Zaher, et al. · Journal of the National Comprehensive Cancer Network

85 Radical treatment rates for early stage lung cancer

2012 · A. Brown, K. Fitzgerald, et al. · Lung Cancer

3D Magnetic Resonance Spectroscopy Without Endorectal Coil in Prostate Cancer Patients Undergoing Androgen Deprivation and External Beam Radiation Therapy

2007 · G. Sasso, A. Zapotoczna, et al. · International Journal of Radiation Oncology*Biology*Physics

Works count: 5

Citation count: 29

H-index: 2

I10-index: 2